The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
A French prospective pilot study for identifying dihydropyrimidine dehydrogenase (DPD) deficiency in breast cancer patients (pts) receiving capecitabine (cap).
Marie-Christine Etienne-Grimaldi
No relevant relationships to disclose
Jean-Marc Ferrero
No relevant relationships to disclose
Fabienne Thomas
No relevant relationships to disclose
Christine Bobin-Dubigeon
No relevant relationships to disclose
Jean Louis Merlin
No relevant relationships to disclose
Frederic Pinguet
No relevant relationships to disclose
Christophe Ferrand
No relevant relationships to disclose
Jean-Christophe Boyer
No relevant relationships to disclose
Gilles Romieu
No relevant relationships to disclose
Thomas Bachelot
No relevant relationships to disclose
Xavier Pivot
No relevant relationships to disclose
Veronique Dieras
No relevant relationships to disclose
Remy Largillier
No relevant relationships to disclose
Mireille Mousseau
No relevant relationships to disclose
Anthony Goncalves
No relevant relationships to disclose
Henri Hubert Roche
No relevant relationships to disclose
Jacques Bonneterre
No relevant relationships to disclose
Beatrice De Clercq
No relevant relationships to disclose
Gerard Milano
No relevant relationships to disclose